These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1634340)

  • 1. Collagen gel contraction by cells associated with proliferative vitreoretinopathy.
    Guidry C; McFarland RJ; Morris R; Witherspoon CD; Hook M
    Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2429-35. PubMed ID: 1634340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines and serum cause alpha 2 beta 1 integrin-mediated contraction of collagen gels by cultured retinal pigment epithelial cells.
    Hunt RC; Pakalnis VA; Choudhury P; Black EP
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):955-63. PubMed ID: 8125758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative vitreo-retinal disorders: experimental models in vivo and in vitro.
    Martini B
    Acta Ophthalmol Suppl (1985); 1992; (201):1-63. PubMed ID: 1322004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proliferative vitreoretinopathy: new discoveries in pathophysiology and therapy].
    Wiedemann P; Weller M; Heimann K
    Klin Monbl Augenheilkd; 1990 Nov; 197(5):355-61. PubMed ID: 2290290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathophysiology of proliferative vitreoretinopathy.
    Wiedemann P; Weller M
    Acta Ophthalmol Suppl (1985); 1988; 189():3-15. PubMed ID: 2851252
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytokines cause cultured retinal pigment epithelial cells to secrete metalloproteinases and to contract collagen gels.
    Hunt RC; Fox A; al Pakalnis V; Sigel MM; Kosnosky W; Choudhury P; Black EP
    Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3179-86. PubMed ID: 8407227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of TGF-beta and TGF-beta neutralizing antibodies on fibroblast-induced collagen gel contraction: implications for proliferative vitreoretinopathy.
    Pena RA; Jerdan JA; Glaser BM
    Invest Ophthalmol Vis Sci; 1994 May; 35(6):2804-8. PubMed ID: 8188474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of platelet-derived growth factor by interleukin-1 beta and transforming growth factor-beta-stimulated retinal pigment epithelial cells leads to contraction of collagen gels.
    Choudhury P; Chen W; Hunt RC
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):824-33. PubMed ID: 9112977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro studies of the contractility of cell types involved in proliferative vitreoretinopathy.
    Mazure A; Grierson I
    Invest Ophthalmol Vis Sci; 1992 Nov; 33(12):3407-16. PubMed ID: 1428714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative vitreoretinopathy. Ultrastructural study of 20 retroretinal membranes removed by vitreous surgery.
    Schwartz D; de la Cruz ZC; Green WR; Michels RG
    Retina; 1988; 8(4):275-81. PubMed ID: 3231920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RPE-mediated collagen gel contraction. Inhibition by colchicine and stimulation by TGF-beta.
    Raymond MC; Thompson JT
    Invest Ophthalmol Vis Sci; 1990 Jun; 31(6):1079-86. PubMed ID: 2354911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contractile elements in proliferative retinal diseases].
    Molitor R; Esser P; Weller M; Wiedemann P; Heimann K
    Ophthalmologe; 1992 Feb; 89(1):34-8. PubMed ID: 1581690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of pigment content, intracellular calcium and cyclic AMP on the ability of human retinal pigment epithelial cells to contract collagen gels.
    Smith-Thomas LC; Richardson PS; Rennie IG; Palmer I; Boulton M; Sheridan C; MacNeil S
    Curr Eye Res; 2000 Jul; 21(1):518-29. PubMed ID: 11035531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subretinal membranes in proliferative vitreoretinopathy. An immunohistochemical study.
    García-Arumí J; Corcostegui B; Tallada N
    Retina; 1992; 12(3 Suppl):S55-9. PubMed ID: 1280852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of proliferative vitreoretinopathy. Modulation of retinal pigment epithelial cell functions by vitreous and macrophages.
    Kirchhof B; Sorgente N
    Dev Ophthalmol; 1989; 16():1-53. PubMed ID: 2676632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in epiretinal membrane components with clinical duration of the proliferative tissue.
    Morino I; Hiscott P; McKechnie N; Grierson I
    Br J Ophthalmol; 1990 Jul; 74(7):393-9. PubMed ID: 2378854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glial cells in culture of preretinal membrane of proliferative vitreoretinopathy.
    Yamashita H; Hori S; Kitano S; Ishii Y; Masuda K
    Jpn J Ophthalmol; 1985; 29(1):42-53. PubMed ID: 3892106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-vascular vitreoretinopathy: the cells and the cellular basis of contraction.
    Grierson I; Mazure A; Hogg P; Hiscott P; Sheridan C; Wong D
    Eye (Lond); 1996; 10 ( Pt 6)():671-84. PubMed ID: 9091362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells.
    Casaroli-Marano RP; Pagan R; Vilaró S
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2062-72. PubMed ID: 10440262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative activity and immunohistochemical cell differentiation in human epiretinal membranes.
    Heidenkummer HP; Kampik A
    Ger J Ophthalmol; 1992; 1(3-4):170-5. PubMed ID: 1483131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.